TAMURA, G. Genetic and epigenetic alterations of tumor suppressor and tumor –
related genes in gastric cancer. Histology and histopathology, Murcia, v.17, n.1,
p.323-329, 2002.
TAMURA, G. Molecular pathogenesis of adenoma and differentiated
adenocarcinoma of the stomach. Pathology International, Victoria, v.46, n.11, p.
834-841, 1996.
TAMURA, G.; et al. Microsatellite alterations in adenoma and differentiated
adenocarcinoma of the stomach. Cancer Research, Philadelphia, v.55, n.9, p.1933-
1936, 1995.
TRAYNOR, O.; et al. Diagnostic and prognotic problems in early gastric cancer. The
American Journal of Surgery, New York, v.154, p.516-519, 1987.
XIANGMING, C.; et al. Coocurrence of reduced expression of alfa-catenina and
overexpression of p53 is a predictor of linphonode metastasis in early gastric cancer.
Oncology, Basel, v.57, p.131-137,1999.
WANG, J.; et al. Alterations of APC, c-met, and p53 Genes in Tumor Tissue and
Serum of Patients with Gastric Cancers. Journal of Surgical Research,
Philadelphia, v.120, n.2, p.242-248, 2004.
WANG, J.; et al. Mutations of p53 gene in gastric carcinoma in Taiwan. Anticancer
research, Athens, v.21, n.1b, p.513-520, 2001.
WU, M.S.; et al. Genetic alterations in gastric cancer: relation to histological
subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology,
Philadelphia, v.112, n.5, p.1457-1465, 1997.
WU, M-S.; et al. Epstein-Barr virus–associated gastric carcinomas : relation to H.
pylori infection and genetic alterations. Gastroenterology, Philadelphia, v.118, p.
1031-1038,2000.
YASUI, W.;et al. Molecular-pathological prognostic factors of gastric cancer: a
review. Gastric Cancer, Tokyo, v.8, n.2, p.86-94, 2005.
YI, S.Y.; LEE, W.J. A p53 genetic polymorphism of gastric cancer: Difference
between early gastric cancer and advanced gastric cancer. World Journal of
Gastroenterology, Beijing, v.12, n.40, p.6536-6539, 2006.